Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. (Q55070063)
Jump to navigation
Jump to search
scientific article published on 24 November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. |
scientific article published on 24 November 2014 |
Statements
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. (English)
1 reference
Zahir Amoura
1 reference
Julien Haroche
1 reference
Fleur Cohen-Aubart
1 reference
Jean-François Emile
1 reference
Philippe Maksud
1 reference
Aurélie Drier
1 reference
Dan Tolédano
1 reference
Stéphane Barete
1 reference
Frédéric Charlotte
1 reference
Philippe Cluzel
1 reference
Jean Donadieu
1 reference
Neïla Benameur
1 reference
Philippe A Grenier
1 reference
Sophie Besnard
1 reference
Jean-Paul Ory
1 reference
François Lifermann
1 reference
Ahmed Idbaih
1 reference
Brigitte Granel
1 reference
Bruno Graffin
1 reference
Baptiste Hervier
1 reference
Laurent Arnaud
1 reference
24 November 2014
1 reference
33
1 reference
5
1 reference
411-418
1 reference